Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 3, September 2005
Page(s) 290 - 295
DOI https://doi.org/10.1051/ject/200537290
Published online 15 September 2005
  1. Laurent TC. Structure of hyaluronic acid. In: Balazs ED, ed. Chemistry and Molecular Biology of the Intercellular Matrix. London: Academic; 1970;703–712. [Google Scholar]
  2. Balazs EA, Denlinger JL. Clinical uses of hyaluronan. Ciba Found Symp. 1989;142:265–75. [Google Scholar]
  3. Magnani A, Albanese A, Lamponi S, Barbucci R. Blood-interaction performance of differently sulphated hyaluronic acids. Thrombosis Research. 1996;81:383–95. [CrossRef] [PubMed] [Google Scholar]
  4. Griffith KE, Vasquez MR, Beckly PD, Lalone BJ. Predicting oxygenator clinical performance from laboratory in vitro setting. J Extra Corpor Technol. 1994;26:114–20. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Tanaka M, Motomura T, Kawada M, et al. Blood compatible aspects of poly(2-methoxyethylacrylate) relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials. 2000;21:1471–81. [CrossRef] [PubMed] [Google Scholar]
  6. Abatangelo G, Barbucci R, Brun P, Lamponi S. Biocompatibility and enzymatic degradation studies on sulphated hyaluronic acid derivatives. Biomaterials. 1997;18:1411–5. [CrossRef] [PubMed] [Google Scholar]
  7. Larsson R. Biocompatible surfaces prepared by immobilized heparin or hyaluronate. Acta Otolaryngol. 1987;442:S44–9. [CrossRef] [Google Scholar]
  8. Lowry KL, Beavers EM. Resistance of hyaluronate coatings to hyaluronidase. J Biomed Mater Res. 1994;28:861–4. [CrossRef] [PubMed] [Google Scholar]
  9. DeFife KM, Shive MS, Hagen KM, Clapper DL, Anderson JM. Effects of Photochemically immobilized polymer coatings on protein adsorption, cell adhesion, and foreign-body reaction to silicone rubber. J Biomed Mater Res. 1999;44:289–307. [Google Scholar]
  10. Niimi Y, Ichinose F, Ishiguro Y, et al. The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption. Anesth Analg. 1999;89:573–7. [CrossRef] [PubMed] [Google Scholar]
  11. Sinci V, Kalaycioglu S, Gunaydin S, et al. Evaluation of heparin coated circuits with full heparin dose strategy. Ann Thorac Cardiovasc Surg. 1999;5:156–63. [Google Scholar]
  12. Gunaydin S, Farsak B, Kocakulak M, Sari T, Yorgancioglu C, Zorlutuna Y. Clinical performance and biocompatibility of poly (2methoxyethylacrylate) coated extracorporeal circuits. Ann Thorac Surg. 2002;74:819–24. [CrossRef] [Google Scholar]
  13. Kocakulak M, Kocum C, Saber R, et al. Investigation of blood compatibility of PMEA coated extracorporeal circuits. J Bioact Compat Poly. 2002;17:343–56. [CrossRef] [Google Scholar]
  14. Gunaydin S. Clinical significance of coated extracorporeal circuits:A review of novel technologies. Perfusion. 2004;19:S33–41. [CrossRef] [PubMed] [Google Scholar]
  15. Stammers AH. Biocompatibility of Trillium biopassive surface coated oxygenator during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2001;15:539–41. [CrossRef] [Google Scholar]
  16. Gunaydin S. Emerging technologies in biocompatible surface modifying additives: Quest for physiologic cardiopulmonary bypass. Curr Med Chem-Cardiovasc Hematologic Agents. 2004;2:295–302. [CrossRef] [Google Scholar]
  17. Gourlay T. Biomaterial development for cardiopulmonary bypass. Perfusion. 2001;16:381–90. [CrossRef] [PubMed] [Google Scholar]
  18. Vijay V, McCusker K. Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass. Perfusion. 2003;18:S41–5. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.